Category:Biopharmaceuticals

Biopharmaceutical companies discover, develop and commercialization of products for the prevention and cure of human, animal and plant diseases utilizing genetically modified or modified live or killed biologics. Biopharmaceutical should be translate new discoveries into viable therapies that could be produced on a large scale and delivered to patients across the globe required overcoming many diseases. Biopharmaceutical manufacturing, in particular, has presented major challenges, even to the industry's leaders. In addition to the inherent difficulties associated with a production platform based on molecular and cellular biology, biopharmaceutical manufacturing always has been subject to the vicissitudes of unpredictable clinical trials, regulatory requirements, product approvals, and market demand. Biopharmaceutical industries need to invest in expensive manufacturing facilities before product approval, the challenges take on the multiple dimensions of technology, logistics, and economics.